Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[366 breast cancer patients and 307 controls were genotyped for SNPs (n?=?41) in the F2, F3 (TF), F5, F7, F10, TFPI and EPCR genes, and assayed for plasma coagulation markers (thrombin generation, activated protein C (APC) resistance, D-dimer, antithrombin, protein C, protein S, and TF pathway inhibitor (TFPI)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[366 breast cancer patients and 307 controls were genotyped for SNPs (n?=?41) in the F2, F3 (TF), F5, F7, F10, TFPI and EPCR genes, and assayed for plasma coagulation markers (thrombin generation, activated protein C (APC) resistance, D-dimer, antithrombin, protein C, protein S, and TF pathway inhibitor (TFPI)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[366 breast cancer patients and 307 controls were genotyped for SNPs (n?=?41) in the F2, F3 (TF), F5, F7, F10, TFPI and EPCR genes, and assayed for plasma coagulation markers (thrombin generation, activated protein C (APC) resistance, D-dimer, antithrombin, protein C, protein S, and TF pathway inhibitor (TFPI)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[366 breast cancer patients and 307 controls were genotyped for SNPs (n?=?41) in the F2, F3 (TF), F5, F7, F10, TFPI and EPCR genes, and assayed for plasma coagulation markers (thrombin generation, activated protein C (APC) resistance, D-dimer, antithrombin, protein C, protein S, and TF pathway inhibitor (TFPI)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[366 breast cancer patients and 307 controls were genotyped for SNPs (n?=?41) in the F2, F3 (TF), F5, F7, F10, TFPI and EPCR genes, and assayed for plasma coagulation markers (thrombin generation, activated protein C (APC) resistance, D-dimer, antithrombin, protein C, protein S, and TF pathway inhibitor (TFPI)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1238382.RARFpYyiBH74PODwfdKjj4luw53VgBcvrG-hLBJwCW90g130_assertion description "[366 breast cancer patients and 307 controls were genotyped for SNPs (n?=?41) in the F2, F3 (TF), F5, F7, F10, TFPI and EPCR genes, and assayed for plasma coagulation markers (thrombin generation, activated protein C (APC) resistance, D-dimer, antithrombin, protein C, protein S, and TF pathway inhibitor (TFPI)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238382.RARFpYyiBH74PODwfdKjj4luw53VgBcvrG-hLBJwCW90g130_provenance.
• NP1238384.RAbmj5JEA1F6lNrQne2O_bAzcjsaZzKtxsurwaeJ_9Xdo130_assertion description "[366 breast cancer patients and 307 controls were genotyped for SNPs (n?=?41) in the F2, F3 (TF), F5, F7, F10, TFPI and EPCR genes, and assayed for plasma coagulation markers (thrombin generation, activated protein C (APC) resistance, D-dimer, antithrombin, protein C, protein S, and TF pathway inhibitor (TFPI)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238384.RAbmj5JEA1F6lNrQne2O_bAzcjsaZzKtxsurwaeJ_9Xdo130_provenance.
• NP1238391.RAXVzudLxxOtfF3F2RoZFL-t08U9HmF_hBa6pb07pCy1Y130_assertion description "[366 breast cancer patients and 307 controls were genotyped for SNPs (n?=?41) in the F2, F3 (TF), F5, F7, F10, TFPI and EPCR genes, and assayed for plasma coagulation markers (thrombin generation, activated protein C (APC) resistance, D-dimer, antithrombin, protein C, protein S, and TF pathway inhibitor (TFPI)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238391.RAXVzudLxxOtfF3F2RoZFL-t08U9HmF_hBa6pb07pCy1Y130_provenance.
• NP1238387.RAhvEFRRYTmH69Odi5tVnWqJPaI0vsaL_piH7WZauMXqo130_assertion description "[366 breast cancer patients and 307 controls were genotyped for SNPs (n?=?41) in the F2, F3 (TF), F5, F7, F10, TFPI and EPCR genes, and assayed for plasma coagulation markers (thrombin generation, activated protein C (APC) resistance, D-dimer, antithrombin, protein C, protein S, and TF pathway inhibitor (TFPI)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238387.RAhvEFRRYTmH69Odi5tVnWqJPaI0vsaL_piH7WZauMXqo130_provenance.
• NP1238388.RAqEKRfmKIvzFDyBcYO53pk_6Uvu62KAqF5_xa3n2lGi8130_assertion description "[366 breast cancer patients and 307 controls were genotyped for SNPs (n?=?41) in the F2, F3 (TF), F5, F7, F10, TFPI and EPCR genes, and assayed for plasma coagulation markers (thrombin generation, activated protein C (APC) resistance, D-dimer, antithrombin, protein C, protein S, and TF pathway inhibitor (TFPI)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238388.RAqEKRfmKIvzFDyBcYO53pk_6Uvu62KAqF5_xa3n2lGi8130_provenance.
• NP1238393.RAsw9ZknJSndFn6rkFX0afCM-19GfbmwVzbwv0hkCtsjg130_assertion description "[366 breast cancer patients and 307 controls were genotyped for SNPs (n?=?41) in the F2, F3 (TF), F5, F7, F10, TFPI and EPCR genes, and assayed for plasma coagulation markers (thrombin generation, activated protein C (APC) resistance, D-dimer, antithrombin, protein C, protein S, and TF pathway inhibitor (TFPI)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238393.RAsw9ZknJSndFn6rkFX0afCM-19GfbmwVzbwv0hkCtsjg130_provenance.